ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 26

Gray Matter Volume Loss in Youth with SLE

Andrea Knight1, Michelle Vickery2, Arastoo Vossough3, Guray Erus4, Jimit Doshi5 and Susan Furth6, 1Center for Pediatric Clinical Effectiveness & PolicyLab, Philadelphia, PA, 2PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 3Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Section on Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, 5Section of Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, 6Division of Nephrology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Lupus, Neuroimaging, neurologic involvement and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, May 20, 2017

Title: Clinical and Therapeutic Poster Breakout II

Session Type: Abstract Submissions

Session Time: 5:15PM-5:45PM

Background/Purpose: Neuropsychiatric SLE in children and adolescents presents diagnostic challenge due to limitations of conventional magnetic resonance imaging (MRI) to detect clinically relevant brain changes. We examined structural brain abnormalities in pediatric-onset SLE (pSLE) utilizing advanced MRI techniques.

Methods: We conducted a cross-sectional analysis of clinically-obtained brain MRI images from subjects with pSLE, and compared them to existing brain MRI images from age and sex-matched controls from another study.  All images were obtained between 2007 and 2015 on the same scanner at 3T using a T1-weighted MPRAGE (magnetization-prepared rapid, acquisition gradient echo) protocol. We used an advanced multi-atlas segmentation algorithm to divide the brain into 154 anatomical regions of interest (ROIs), organized hierarchically within larger brain structures. We calculated volumes of individual ROIs and larger brain structures, and compared volumetric measurements from pSLE and control subjects using univariate paired t-tests. ROIs with significant group differences after Bonferroni correction for multiple comparisons (q<0.01, where q=p/#ROIs tested) were reported. A neuroradiologist, blinded to the volumetric results, performed conventional re-reads of MRIs for pSLE subjects.

Results: We matched 28 SLE adolescents to 28 controls, comprised of 89% females with a mean age of 15.9 (SD=3.6). Median disease duration for SLE subjects was 1.1 years (interquartile range, IQR 0.3, 2.9), and median SLEDAI score was 5 (IQR 1, 11). There was a history of nephritis in 12 (43%), seizures and/or stroke in 5 (18%), anti-phospholipid syndrome in 3 (11%), depression and/or anxiety in 18 (64%). Glucocorticoids were used by 89% of pSLE subjects at the time of MRI (median prednisone dose=5 mg, IQR=10,25). Conventional pSLE MRI reads indicated T2 hyperintensities in 48% and mild diffuse volume loss in 28%. Using advanced segmentation, total brain volume did not differ between groups, but volumes in specific gray matter ROIs were significantly decreased in pSLE subjects compared to controls (q<0.01). These ROIs are involved in: decision-making, memory, and social cognition (right medial frontal cortex); empathy, emotional memory and processing (right temporal pole, left anterior cingulate gyrus); topographical and facial recognition (right lingual gyrus); language processing (left parietal lateral cortex, bilateral planum polare, frontal operculum); visual and spatial attention (bilateral cuneus).

Conclusion: Compared to healthy peers, children and adolescents with SLE have decreased gray matter volumes in regions involved in executive function, social cognition, language and emotional processing. Future study should examine the functional correlates of these structural brain abnormalities.


Disclosure: A. Knight, None; M. Vickery, None; A. Vossough, None; G. Erus, None; J. Doshi, None; S. Furth, None.

To cite this abstract in AMA style:

Knight A, Vickery M, Vossough A, Erus G, Doshi J, Furth S. Gray Matter Volume Loss in Youth with SLE [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/gray-matter-volume-loss-in-youth-with-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gray-matter-volume-loss-in-youth-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology